To investigate the long-term disease course of patients with recently deteriorated systemic sclerosis (SSC)-interstitial lung disease (ILD) undergoing continuous immunosuppressive treatment with cyclophosphamide (CYC) as induction therapy.
Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders / Iudici, Michele; Cuomo, Giovanna; Vettori, Serena; Bocchino, Marialuisa; SANDUZZI ZAMPARELLI, Alessandro; Cappabianca, Salvatore; Valentini, Gabriele. - In: SEMINARS IN ARTHRITIS AND RHEUMATISM. - ISSN 0049-0172. - 44:4(2015), pp. 437-44-444. [10.1016/j.semarthrit.2014.09.003]
Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders
BOCCHINO, MARIALUISA;SANDUZZI ZAMPARELLI, ALESSANDRO;
2015
Abstract
To investigate the long-term disease course of patients with recently deteriorated systemic sclerosis (SSC)-interstitial lung disease (ILD) undergoing continuous immunosuppressive treatment with cyclophosphamide (CYC) as induction therapy.File | Dimensione | Formato | |
---|---|---|---|
PIIS0049017214002194.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
397.05 kB
Formato
Adobe PDF
|
397.05 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.